For Patients & General Readers

Psoriasis is a chronic autoimmune skin condition where the immune system mistakenly attacks healthy skin cells, causing them to grow too quickly. This leads to the formation of red, scaly patches on the skin. While it can affect anyone, it often begins in early adulthood and can significantly impact quality of life due to its appearance and potential for joint pain.

Clinical Overview

Psoriasis is a chronic inflammatory skin disease characterized by accelerated keratinocyte proliferation, leading to well-demarcated erythematous plaques with silvery scales. It is driven by dysregulation of the immune system, primarily involving T-helper 1 (Th1) and Th17 cells, and is associated with significant comorbidities.

Clinical Presentation

Well-demarcated erythematous plaques with silvery-white scales.
Commonly affects extensor surfaces (elbows, knees), scalp, and trunk.
Can present with nail changes, including pitting, onycholysis, and discoloration.
May be associated with psoriatic arthritis, causing joint pain, stiffness, and swelling.
Variable severity, ranging from localized patches to generalized erythroderma.

Signs & Symptoms

Symptoms (Patient-Reported)

Itching (pruritus)
Burning or stinging sensation
Pain or tenderness in affected areas
Dry, cracked skin that may bleed
Thickened, ridged, or pitted nails
Joint pain, stiffness, and swelling (if psoriatic arthritis is present)

Signs (Clinician-Observed)

Erythematous plaques with characteristic silvery scales.
Auspitz sign (pinpoint bleeding when scales are removed).
Koebner phenomenon (lesions appearing at sites of trauma).
Nail changes: pitting, onycholysis, subungual hyperkeratosis, oil spots.

Differential Diagnoses

Condition	Distinguishing Feature
Eczema (Atopic Dermatitis)	Typically presents with ill-defined, erythematous, and often weeping or crusted lesions, with intense pruritus. Psoriasis has well-demarcated plaques with silvery scales.
Pityriasis Rosea	Characterized by a herald patch followed by a generalized rash of smaller oval, pinkish-red lesions with fine scale, often distributed in a 'Christmas tree' pattern on the trunk. Lesions are typically less thick than psoriasis.
Tinea Corporis (Ringworm)	Fungal infection presenting as annular, erythematous, scaly plaques with central clearing. Microscopic examination of scales for hyphae confirms diagnosis.
Secondary Syphilis	Can present with widespread papulosquamous lesions, often involving palms and soles, which can mimic psoriasis. Serological testing is crucial for diagnosis.
Seborrheic Dermatitis	Affects areas rich in sebaceous glands (scalp, face, chest) and presents with greasy, yellowish scales on erythematous skin. Psoriasis scales are typically silvery-white and drier.
Lichen Planus	Characterized by the '4 Ps': purple, polygonal, pruritic papules and plaques. Oral lesions are common. Histopathology is often diagnostic.

Red Flags — Seek Immediate Care

Generalized erythroderma (psoriatic erythroderma), indicating a potential for systemic involvement and fluid/electrolyte imbalance.
Psoriatic arthritis with rapidly progressing joint damage or systemic inflammatory symptoms.
Signs of infection on psoriatic lesions, especially in patients on immunosuppressive therapy.
Development of pustular psoriasis, which can be a medical emergency due to potential for fever and malaise.

Key Investigations

Clinical diagnosis based on characteristic morphology and distribution.
Skin biopsy for histopathological confirmation (especially for atypical presentations).
Rheumatological evaluation and imaging (X-rays, MRI) for suspected psoriatic arthritis.
Blood tests to assess for comorbidities such as metabolic syndrome, cardiovascular disease, and inflammatory markers (ESR, CRP) if indicated.

Management Overview

Management of psoriasis is multimodal and aims to reduce inflammation, slow keratinocyte proliferation, and improve quality of life. Treatment strategies range from topical agents (corticosteroids, vitamin D analogs, retinoids) for mild to moderate disease, to phototherapy and systemic agents (methotrexate, cyclosporine, biologics) for moderate to severe or refractory cases.

Disclaimer: This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for diagnosis and treatment. TruelyserMD does not replace clinical judgement.